{"DataElement":{"publicId":"7171877","version":"1","preferredName":"Patient Systemic Therapy Receive Clinical Trial Eligibility Criteria Type","preferredDefinition":"The kind of treatment the patient will receive as outlined in the in the eligibility criteria of the protocol.","longName":"ELIG_TX_TP","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"7170132","version":"1","preferredName":"Patient Systemic Therapy To Receive Clinical Trial Eligibility Criteria","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body._Used as a function word to indicate direction, purpose, or movement._To take, accept, or get something offered._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2233604v1.0:7170130v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7170130","version":"1","preferredName":"Systemic Therapy To Receive Clinical Trial Eligibility Criteria","preferredDefinition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.:Used as a function word to indicate direction, purpose, or movement.:To take, accept, or get something offered.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C15698:C65107:C25639:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Systemic Therapy","conceptCode":"C15698","definition":"Treatment using substances that travel through the bloodstream, reaching and affecting cells all over the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Receive","conceptCode":"C25639","definition":"To take, accept, or get something offered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E8F8B00-A761-57FA-E053-F662850A2A32","latestVersionIndicator":"Yes","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"ONEDATA","dateModified":"2020-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E8F8B00-A772-57FA-E053-F662850A2A32","latestVersionIndicator":"Yes","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"TAYLORT","dateModified":"2020-02-26","changeDescription":"2/14/20 EA1183/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7169940","version":"1","preferredName":"Therapeutic Procedure Type","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._Something distinguishable as an identifiable class based on common qualities.","longName":"7169940v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"HER2-targeted therapy per ASCO, NCCN, and/or institutional guidelines as indicated for patients with HER2 positive disease.","valueDescription":"HER2 Targeted Therapy Per American Society of Clinical Oncology National Comprehensive Cancer Network Healthcare Facility Guidelines for HER2 Positive Breast Carcinoma","ValueMeaning":{"publicId":"7169945","version":"1","preferredName":"HER2 Targeted Therapy Per American Society of Clinical Oncology National Comprehensive Cancer Network Healthcare Facility Guidelines for HER2 Positive Breast Carcinoma","longName":"7169945","preferredDefinition":"This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.: A type of treatment that uses drugs or other substances, such as monoclonal antibodies, to identify and attack specific cancer cells. Targeted therapy may have fewer side effects than other types of cancer treatments.: For each, generally denoting a ratio.: The world's leading professional organization representing physicians of all oncology disciplines and subspecialties. ASCO sets the standard for cancer care, supports funding for clinical and translational research, fosters the exchange of information related to cancer, including cancer biology, diagnosis, staging, treatment and psychosocial impact.  ASCO provides training in clinical research and patient care and publishes the Journal of Clinical Oncology.: An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.: The buildings and organizations where healthcare services are provided.: Directions or principles presenting current or future rules of policy. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by the convening of expert panels. The text may be cursive or in outline form but is generally a comprehensive guide to problems and approaches in any field of activity. For guidelines in the field of health care and clinical medicine, PRACTICE GUIDELINES is available.: The reason of something.: A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ERBB2 Gene","conceptCode":"C17756","definition":"This gene plays a role in cellular proliferation and is involved in the oncogenic process through amplification and/or overexpression in several cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"8"},{"longName":"Targeted Therapy","conceptCode":"C93352","definition":"A type of cancer treatment that uses testing and medication to more precisely identify and treat cancer. These treatments target and disable genes or proteins necessary to the proliferation of cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"7"},{"longName":"Per","conceptCode":"C65039","definition":"For each, generally denoting a ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"American Society of Clinical Oncology","conceptCode":"C39319","definition":"The world's leading professional organization representing physicians of all oncology disciplines and subspecialties. ASCO sets the standard for cancer care, supports funding for clinical and translational research, fosters the exchange of information related to cancer, including cancer biology, diagnosis, staging, treatment and psychosocial impact.  ASCO provides training in clinical research and patient care and publishes the Journal of Clinical Oncology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"National Comprehensive Cancer Network","conceptCode":"C39471","definition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Healthcare Facility","conceptCode":"C21541","definition":"The buildings and organizations where healthcare services are provided.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Guideline","conceptCode":"C17564","definition":"A systematic statement of policy rules or principles. Guidelines may be developed by government agencies at any level, institutions, professional societies, governing boards, or by convening expert panels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"HER2-Positive Breast Carcinoma","conceptCode":"C53556","definition":"A biologic subset of breast carcinoma defined by high expression of HER2, GRB7, and TRAP100, and by lack of expression of estrogen receptor (ER).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E8F1F79-9D39-69FB-E053-F662850ACDC7","latestVersionIndicator":"Yes","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"TAYLORT","dateModified":"2020-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E8F1F79-9D94-69FB-E053-F662850ACDC7","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"ONEDATA","dateModified":"2020-02-14","deletedIndicator":"No"},{"value":"Chemotherapy per NCCN or institutional standard.","valueDescription":"Chemotherapy Per National Comprehensive Cancer Network Or Healthcare Facility Standard Treatment","ValueMeaning":{"publicId":"7169946","version":"1","preferredName":"Chemotherapy Per National Comprehensive Cancer Network Or Healthcare Facility Standard Treatment","longName":"7169946","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.: For each, generally denoting a ratio.: An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The buildings and organizations where healthcare services are provided.: A therapy approved by a health regulatory authority and in wide use, which is considered to be the standard of care for the management of a specific disease or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Per","conceptCode":"C65039","definition":"For each, generally denoting a ratio.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"National Comprehensive Cancer Network","conceptCode":"C39471","definition":"An alliance of 19 leading US cancer centers, an authoritative source of information to help patients and health professionals make informed decisions about cancer care. Through the collective expertise of its member institutions, the NCCN develops, updates, and disseminates a complete library of clinical practice guidelines. These guidelines are the standard for clinical policy in oncology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Healthcare Facility","conceptCode":"C21541","definition":"The buildings and organizations where healthcare services are provided.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Standard Treatment","conceptCode":"C142696","definition":"A therapy approved by a health regulatory authority and in wide use, which is considered to be the standard of care for the management of a specific disease or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E8F1F79-9D63-69FB-E053-F662850ACDC7","latestVersionIndicator":"Yes","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"ONEDATA","dateModified":"2020-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E8F1F79-9D7C-69FB-E053-F662850ACDC7","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"ONEDATA","dateModified":"2020-02-14","deletedIndicator":"No"},{"value":"Either 1st or 2nd line endocrine therapy for metastatic breast cancer.","valueDescription":"First Or Second Line of Therapy Hormone Therapy For Metastatic Breast Carcinoma","ValueMeaning":{"publicId":"7169942","version":"1","preferredName":"First Or Second Line of Therapy Hormone Therapy For Metastatic Breast Carcinoma","longName":"7169942","preferredDefinition":"Preceding all others in time or space or degree.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: Coming next after the first in position in space or time or degree or magnitude.: The sequence of therapies administered to a patient.: Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.: The reason of something.: A carcinoma that arises from the breast and has metastasized to another anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Line of Therapy","conceptCode":"C133518","definition":"The sequence of therapies administered to a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"For","conceptCode":"C64956","definition":"The reason of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Metastatic Breast Carcinoma","conceptCode":"C153238","definition":"A carcinoma that arises from the breast and has metastasized to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E8F52C0-3964-09AD-E053-F662850A55E6","latestVersionIndicator":"Yes","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"ONEDATA","dateModified":"2020-02-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E8F52C0-397D-09AD-E053-F662850A55E6","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"ONEDATA","dateModified":"2020-02-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2749690","version":"1","preferredName":"Therapeutic Procedure Type","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.:Type; a subdivision of a particular kind of thing.","longName":"C49236:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D35F706-1F30-4E8C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-14","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-05-14","modifiedBy":"ONEDATA","dateModified":"2008-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E8F52C0-3945-09AD-E053-F662850A55E6","latestVersionIndicator":"Yes","beginDate":"2020-02-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-14","modifiedBy":"TAYLORT","dateModified":"2020-02-26","changeDescription":"2/14/20 EA1183/tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Indicate the systemic therapy","type":"Preferred Question Text","description":"Indicate the systemic therapy patient will be receiving","url":null,"context":"ECOG-ACRIN"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9ECCC75D-EB2B-7876-E053-F662850AB4C7","latestVersionIndicator":"Yes","beginDate":"2020-02-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-17","modifiedBy":"SOKKERL","dateModified":"2021-08-19","changeDescription":"2/26/20 tmt released.; 2/17/20 EA1183; tmt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}